1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Cancer of Cervix

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Cancer of Cervix in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gutiérrez-Iglesias, G; Hurtado, Y; López-Marure, R; Palma-Lara, I1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Cancer of Cervix

ArticleYear
Resistance to the antiproliferative effect induced by a short-chain ceramide is associated with an increase of glucosylceramide synthase, P-glycoprotein, and multidrug-resistance gene-1 in cervical cancer cells.
    Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Genes, MDR; Glucosyltransferases; Glycosylation; Humans; Lactosylceramides; Morpholines; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured; Uterine Cervical Neoplasms

2014